P08.02 Lorlatinib in First Line Treatment of Patients With ALK-Positive NSCLC: A Network Meta-Analysis
| Autor: | Gregory, J., Kilvert, H., Williams, T., Cooper, M., Polli, A., Iadeluca, L., Ou, S. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology October 2021 16(10) Supplement:S992-S992 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|